Cargando…

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2

Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutrali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostafavi, Ebrahim, Iravani, Siavash, Varma, Rajender S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Post-Screen (Grey)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330373/ https://www.ncbi.nlm.nih.gov/pubmed/35908684 http://dx.doi.org/10.1016/j.drudis.2022.07.015

Ejemplares similares

Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022)

High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
por: Xu, Tuan, et al.
Publicado: (2021)

Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
por: Aquino-Jarquin, Guillermo
Publicado: (2021)

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021)

Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022)

Nucleosides and emerging viruses: A new story
por: Roy, Vincent, et al.
Publicado: (2022)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

Drug combination therapy for emerging viral diseases
por: Shyr, Zeenat A., et al.
Publicado: (2021)

Exploiting protease activation for therapy
por: Bleuez, Chloe, et al.
Publicado: (2022)

The current status of COVID-19 vaccines. A scoping review
por: Rueda-Fernández, Manuel, et al.
Publicado: (2022)

Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
por: Alharbi, Ebtisam, et al.
Publicado: (2022)

How to build a tumor: An industry perspective
por: Schueler, Julia, et al.
Publicado: (2022)

Nanosponges for Drug Delivery and Cancer Therapy: Recent Advances
por: Iravani, Siavash, et al.
Publicado: (2022)

Harnessing aptamers against COVID-19: A therapeutic strategy
por: Mahmoudi, Ali, et al.
Publicado: (2023)

COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
por: Saifi, Mohd Aslam, et al.
Publicado: (2022)

Nanomedicine approaches to reduce cytokine storms in severe infections
por: Ahmar Rauf, Mohd, et al.
Publicado: (2022)

Impact of COVID-19 on male urogenital health: Success of vaccines
por: Kucukyildiz, Kutay, et al.
Publicado: (2022)

Steps toward nebulization in-use studies to understand the stability of new biological entities
por: Montefusco-Pereira, Carlos Victor
Publicado: (2023)

Eco-friendly synthesis of carbon nanotubes and their cancer theranostic applications
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

SARS-CoV-2: an opportunity for hospital pharmacy
por: Claramunt García, Raquel, et al.
Publicado: (2022)

SARS-CoV-2 infection in ambulatory and hospitalised Spanish children
por: de Ceano-Vivas, María, et al.
Publicado: (2020)

Nervous system: subclinical target of SARS-CoV-2 infection
por: Mariotto, Sara, et al.
Publicado: (2020)

Developing better strategies for school eye health screening in India
por: Reddy, Priya Adhisesha, et al.
Publicado: (2017)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids
por: Zhao, Yi, et al.
Publicado: (2023)

Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy
por: Mio, Catia, et al.
Publicado: (2022)

Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2023)

Single-cell gene expression links SARS-CoV-2 infection and gut serotonin
por: Martin, Alyce M, et al.
Publicado: (2023)

Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results
por: Tan, Shaun S, et al.
Publicado: (2021)

Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection
por: Nashed, Lydia, et al.
Publicado: (2022)

Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
por: Iluta, Sabina, et al.
Publicado: (2022)

MXene-Chitosan Composites and Their Biomedical Potentials
por: Iravani, Parisa, et al.
Publicado: (2022)

Green synthesis, biomedical and biotechnological applications of carbon and graphene quantum dots. A review
por: Iravani, Siavash, et al.
Publicado: (2020)

Plant Pollen Grains: A Move Towards Green Drug and Vaccine Delivery Systems
por: Iravani, Siavash, et al.
Publicado: (2021)

Smart MXene Quantum Dot-Based Nanosystems for Biomedical Applications
por: Iravani, Siavash, et al.
Publicado: (2022)

Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
por: Iravani, Siavash, et al.
Publicado: (2022)

Alginate-Based Micro- and Nanosystems for Targeted Cancer Therapy
por: Iravani, Siavash, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lsnc25932sr5bae81i4bc2v4rj